07-11-2024 |
PM |
|
GDRX |
GoodRx Holdings, Inc. |
2,250 |
0.03 |
0.04 |
0.00 |
GoodRx Holdings Non-GAAP EPS of $0.08 misses by $0.01, revenue of $195.3M misses by $0.35M [11/7/2024 6:09 AM] |
5.05 |
-1.06 (-17.27%) |
5.95 |
-0.16 (-2.62%) |
4.14 - 9.26 |
7,380,916 |
880,000 |
29,423 |
|
|
08-08-2024 |
PM |
|
GDRX |
GoodRx Holdings, Inc. |
3,280 |
0.02 |
0.04 |
0.02 |
GoodRx Holdings Non-GAAP EPS of $0.08 misses by $0.01, revenue of $200.6M in-line [8/8/2024 6:10 AM] |
7.00 |
-1.60 (-18.64%) |
7.50 |
-1.11 (-12.89%) |
4.14 - 9.26 |
5,906,365 |
1,410,000 |
39,304 |
|
|
09-05-2024 |
PM |
|
GDRX |
GoodRx Holdings, Inc. |
2,970 |
0.03 |
0.04 |
0.01 |
GoodRx Holdings beats top-line and bottom-line estimates; initiates Q2 and updates FY24 outlook [5/9/2024 6:08 AM] |
6.92 |
-0.69 (-9.00%) |
7.10 |
-0.51 (-6.70%) |
4.14 - 9.37 |
3,840,597 |
1,090,000 |
98,470 |
|
|
29-02-2024 |
PM |
|
GDRX |
GoodRx Holdings, Inc. |
2,660 |
0.02 |
0.02 |
0.01 |
GoodRx Holdings GAAP EPS of -$0.06 misses by $0.01, revenue of $196.6M beats by $0.73M [2/29/2024 6:05 AM] |
7.82 |
1.35 (20.79%) |
7.09 |
0.62 (9.58%) |
4.14 - 9.37 |
8,022,299 |
1,410,000 |
130,689 |
|
|
09-11-2023 |
PM |
|
GDRX |
GoodRx Holdings, Inc. |
2,150 |
N/A |
0.01 |
0.00 |
GoodRx Holdings reports mixed Q3 earnings; initiates Q4 and FY23 outlook [11/9/2023 6:09 AM] |
4.43 |
-1.04 (-18.92%) |
5.25 |
-0.22 (-4.02%) |
3.82 - 9.37 |
9,114,872 |
1,470,000 |
11,129 |
|
|
09-08-2023 |
PM |
|
GDRX |
GoodRx Holdings, Inc. |
3,440 |
0.02 |
0.01 |
0.02 |
GoodRx Holdings Non-GAAP EPS of $0.07 beats by $0.01, revenue of $189.7M beats by $2.86M [8/9/2023 6:03 AM] |
7.94 |
-0.80 (-9.15%) |
7.81 |
-0.93 (-10.64%) |
3.82 - 10.37 |
3,190,556 |
4,550,000 |
92,368 |
|
|
10-05-2023 |
PM |
Before the open (May 10) |
GDRX |
GoodRx Holdings, Inc. |
1,830 |
0.01 |
0.00 |
0.03 |
GoodRx Holdings Non-GAAP EPS of $0.07 beats by $0.01, revenue of $183.99M beats by $1.9M [5/10/2023 6:05 AM] |
4.79 |
0.10 (2.24%) |
4.48 |
-0.21 (-4.48%) |
3.82 - 10.37 |
2,059,191 |
1,720,000 |
40,597 |
|
|
28-02-2023 |
AH |
4:05 PM ET (Feb 28) |
GDRX |
GoodRx Holdings, Inc. |
2,120 |
0.01 |
-0.01 |
0.01 |
GoodRx Holdings Non-GAAP EPS of $0.07 beats by $0.02, revenue of $184.1M beats by $5.61M, guidance in-line [2/28/2023 4:15 PM] |
5.51 |
0.22 (4.25%) |
5.70 |
0.41 (7.75%) |
3.82 - 20.59 |
3,352,128 |
1,720,000 |
8,649 |
|
|
08-11-2022 |
AH |
4:05 PM ET (Nov 8) |
GDRX |
GoodRx Holdings, Inc. |
1,950 |
N/A |
-0.02 |
-0.01 |
GoodRx Holdings Non-GAAP EPS of $0.07 beats by $0.03, revenue of $187.3M beats by $2.29M [11/8/2022 4:23 PM] |
4.06 |
-1.18 (-22.52%) |
4.47 |
-0.77 (-14.69%) |
3.82 - 43.77 |
5,731,779 |
1,370,000 |
78,197 |
|
|
08-08-2022 |
AH |
4:05 PM ET (Aug 8) |
GDRX |
GoodRx Holdings, Inc. |
2,620 |
0.02 |
-0.02 |
0.00 |
GoodRx Holdings Non-GAAP EPS of $0.06 beats by $0.02, revenue of $191.8M beats by $7.09M [8/8/2022 4:18 PM] |
7.85 |
0.09 (1.16%) |
10.09 |
2.33 (30.03%) |
5.62 - 48.05 |
24,655,449 |
2,540,000 |
1,778,944 |
|
|
09-05-2022 |
AH |
4:05 PM ET (May 9) |
GDRX |
GoodRx Holdings, Inc. |
5,200 |
0.03 |
0.01 |
-0.01 |
GoodRx Holdings Non-GAAP EPS of $0.10 beats by $0.02, revenue of $203.33M beats by $2.72M [5/9/2022 4:13 PM] |
8.22 |
-2.53 (-23.53%) |
7.90 |
-2.85 (-26.51%) |
10.65 - 48.05 |
10,784,864 |
2,831,016 |
1,263,827 |
|
|
28-02-2022 |
AH |
4:05 PM ET (Feb 28) |
GDRX |
GoodRx Holdings, Inc. |
10,200 |
0.01 |
0.03 |
-0.60 |
GoodRx Holdings Non-GAAP EPS of $0.09 misses by $0.01, revenue of $213.3M misses by $4.21M [2/28/2022 4:14 PM] |
16.75 |
-10.65 (-38.89%) |
18.90 |
-8.50 (-31.02%) |
15.91 - 48.05 |
32,530,816 |
1,550,000 |
1,100,195 |
|
|
10-11-2021 |
AH |
4:05 PM ET (Nov 10) |
GDRX |
GoodRx Holdings, Inc. |
17,310 |
-0.01 |
0.01 |
-0.25 |
GoodRx Holdings EPS misses by $0.06, beats on revenue [11/10/2021 4:09 PM] |
39.76 |
-2.19 (-5.22%) |
41.29 |
-0.66 (-1.57%) |
26.66 - 59.67 |
2,637,859 |
1,260,000 |
13,085 |
|
|
12-08-2021 |
PM |
7:30 AM ET (Aug 12) |
GDRX |
GoodRx Holdings, Inc. |
12,220 |
N/A |
0.01 |
0.00 |
GoodRx Holdings EPS beats by $0.06, beats on revenue; issues Q3 guidance [8/12/2021 7:37 AM] |
35.53 |
4.62 (14.95%) |
35.53 |
0.0 (0.00%) |
26.66 - 64.22 |
5,982,816 |
1,500,000 |
1,130 |
|
|
13-05-2021 |
AH |
4:05 PM ET (May 13) |
GDRX |
GoodRx Holdings, Inc. |
12,010 |
-0.01 |
0.00 |
0.00 |
GoodRx Holdings EPS beats by $0.02, misses on revenue [5/13/2021 4:21 PM] |
30.92 |
2.65 (9.37%) |
27.01 |
-1.26 (-4.46%) |
26.66 - 64.22 |
5,935,466 |
2,230,000 |
23,955 |
|
|
11-03-2021 |
AH |
After the close (Mar 11) |
GDRX |
GoodRx Holdings, Inc. |
15,660 |
-0.60 |
-0.50 |
0.00 |
GoodRx Holdings EPS misses by $0.07, beats on revenue [3/11/2021 6:14 PM] |
39.10 |
-4.49 (-10.29%) |
40.60 |
-2.99 (-6.86%) |
33.51 - 64.22 |
7,857,086 |
1,937,312 |
77,942 |
|
|
12-11-2020 |
PM |
Before the open (Nov 12) |
GDRX |
GoodRx Holdings, Inc. |
19,560 |
-0.25 |
-0.03 |
0.00 |
GoodRx Holdings EPS beats by $0.09, beats on revenue [11/12/2020 7:37 AM] |
47.72 |
-3.38 (-6.61%) |
48.18 |
-2.92 (-5.71%) |
45.50 - 64.22 |
3,348,934 |
1,298,548 |
130,404 |
|
|